Section Arrow
Quote
BJDX.NASDAQ
- Bluejay Diagnostics Inc
Quotes are at least 15-min delayed:2025/12/07 19:10 EST
Regular Hours
Last
 1.22
+0.03 (+2.52%)
Day High 
1.24 
Prev. Close
1.19 
1-M High
1.77 
Volume 
46.56K 
Bid
1.25
Ask
1.27
Day Low
1.19 
Open
1.24 
1-M Low
1.13 
Market Cap 
2.16M 
Currency 美元 
P/E 0 
%Yield -- 
10-SMA 1.28 
20-SMA 1.41 
50-SMA 1.9 
52-W High 10.2 
52-W Low 1.13 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
499.26/-0.29
Enterprise Value
2.27M
Balance Sheet
Book Value Per Share
2.04
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
MXCTMaxCyte1.47-0.11-6.96%-- 
PACBPacific Biosciences of California2.39-0.13-5.16%-- 
BSXBoston Scientific Corp97.52-0.2-0.20%52.14PE
PFSAProfusa Inc0.177-0.0045-2.48%-- 
MDTMedtronic plc101.36-0.63-0.62%28.37PE
Industry overview quotes are at least 15 minutes delayed
Business Description
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from 'sample-to-result' to help medical professionals make earlier and better triage/treatment decisions.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.